本文/YA7282D
|
|
- そうりん やまがた
- 5 years ago
- Views:
Transcription
1 RTK G GPCR α PI - vasculogenesis angiogenesis phosphatidylinositol PI - PI K PI PI K PI K Vps PI K PI K α PI K PI K-C α PI K PI K PI K A pα β γ δ PI P PI P PI K PI K-C α, -C β, -C γ Waterfield PI K_ D C α C β PI PIP C α C β C α C β C γ Vps Vacuolar protein sorting- hvps PIP PI K PIP PI P PI P PI P PI P PH pleckstrin homology Akt PH PI K Akt G PI K Ras Rho Rho Rac cdc Arf GEF GTPase GAP B pα pβ KO EE
2 7 7 6 生化学 第8 5巻 第9号 図1 PI3キナーゼ ファミリーの分類 A とホスファチジルイノシトール PtdIns 情報伝達経路 B みにれびゆう
3 I-A PI K pδ KO Vanhaesebroeck TLR pδ I-B pγ KO pγ pα KO pα A VEGF-A Akt Rho pα in vivo VEGF-Akt Rho PI K PtdInsP FYVE EEA early endosome antigen- C α PI K C α C α in vitro C β KO C β KO in vitro LPA C β RNA RNAi α PI K-C α C α C α KO C α E E E A C α KO C α KO CKO SM α-cre; C α flox flox Nkx - - Cre; C α flox flox CKO C α ΔEC Tie -Cre; C α flox flox CKO B C α C α ΔEC C α C α-cko Cdh PAC -CreER T ; C α flox flox C α iδec C α iδec C α P P C α iδec C α PI K C α in vivo C α iδec C α iδec Lewis LLC B B -BL C α iδec C α iδec C α iδec
4 PI K-C α
5 NG C α RNAi C α HUVEC VEGF-A pα VEGF-A PI K pβ C β Vps C α HUVEC VEGF-A VEGF Akt MAP ERK PAK NO enos VEGF PI K pα C α G RhoA RhoA Rho MYPT VEGF-A - S P RacFGF Rap C α C α G C α C α C α PIP mrfp xfyve PIP PIP C α FYVE pα Vps C α PIP C α TGN PIP GFP VE C VE C α-rhoa RhoA FRET Raichu-RhoA RhoA VEGF-A RhoA RhoA EEA C α RhoA D PIP RhoA C α RhoA VEGF VEGFR VEGF-A VEGFR FYVE C α C α VEGF-A VEGFR VEGFR C α Dynasore VEGF-A RhoA VE- C α VEGFR RhoA VE GPCR S P S P S P C α S P G Gi Rac VEGF RhoA S P RacFRET EEA C α RacS P S P C α C α PI K VEGF-A S P PI K-C α
6 C α PI K C α PIP E C α C α PI K pα β PI K Akt VE- APPL SARA Vps PI K PIP Vps PI K C α PI K Adams, R.H. & Alitalo, K.Nat. Rev. Mol. Cell Biol.,,. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B.Nat. Rev. Mol. Cell Biol.,,. Yoshioka, K., Yoshida, K., Cui, H., Wakayama, T., Takuwa, N., Okamoto, Y., Du, W., Qi, X., Asanuma, K., Sugihara, K., Aki, S., Miyazawa, H., Biswas, K., Nagakura, C., Ueno, M., Iseki, S., Schwartz, R.J., Okamoto, H., Sasaki, T., Matsui, O., Asano, M., Adams, R.H., Takakura, N., & Takuwa, Y. Nat. Med.,,. Biswas, K., Yoshioka, K., Asanuma, K., Okamoto, Y., Takuwa, N., Sasaki, T., & Takuwa, Y.J. Biol. Chem.,,. Bi, L., Okabe, I., Bernard, D.J., Wynshaw-Boris, A., & Nussbaum, R.L.J. Biol. Chem.,,. Bi, L., Okabe, I., Bernard, D.J., & Nussbaum, R.L. Mamm. Genom.,,. Aksoy, E., Taboubi, S., Torres, D., Delbauve, S., Hachani, A., Whitehead, M.A., Pearce, W.P., Berenjeno-Martin, I., Nock, G., Filloux, A., Beyaert, R., Flamand, V., & Vanhaesebroeck, B.Nat. Immunol.,,. Crackower, M.A., Oudit, G.Y., Kozieradzki, I., Sarao, R., Sun, H., Sasaki, T., Hirsch, E., Suzuki, A., Shioi, T., Irie-Sasaki, J., Sah, R., Cheng, H.Y., Rybin, V.O., Lembo, G., Fratta, L., Oliveira-dos-Santos, A.J., Benovic, J.L., Kahn, C.R., Izumo, S., Steinberg, S.F., Wymann, M.P., Backx, P.H., & Penninger, J. M.Cell,,. Graupera, M., Guillermet-Guibert, J., Foukas, L.C., Phng, L.K., Cain, R.J., Salpekar, A., Pearce, W., Meek, S., Millan, J., Cutillas, P.R., Smith, A.J., Ridley, A.J., Ruhrberg, C., Gerhardt, H., & Vanhaesebroeck, B.Nature,,. Domin, J., Gaidarov, I., Smith, M.E., Keen, J.H., & Waterfield, M.D.J. Boil. Chem.,,. Di Paolo, G. & De Camilli, P.Nature,,. Harada, K., Truong, A.N., Cai, T., & Khavari, P.A. Mol. Cell Biol.,,. Domin, J., Harper, L., Aubyn, D., Wheeler, M., Florey, O., Haskard, D., Yuan, M., & Zicha, D.J. Cell Physiol.,,. Ryu, Y., Takuwa, N., Sugimoto, N., Sakurada, S., Usui, S., Okamoto, H., Matsui, O., & Takuwa, Y.Circ. Res.,,. Zoncu, R., Perera, R.M., Balkin, D.M., Pirruccello, M., Toomre, D., & De Camilli, P.Cell,,. Kang, J.S., Liu, C., & Derynck, R.Trends Cell Biol.,,. Gould, G.W. & Lippincott-Schwartz, J.Nat. Rev. Mol. Cell Biol.,,. Physiological roles of Class II PI kinase-c α in endothelial cells Kazuaki Yoshioka, Noriko Takuwa, Yasuo Okamoto and Yoh Takuwa Department of Physiology, Kanazawa University School of Medicine, Takaramachi, Kanazawa, Ishikawa, Japan, Department of Health and Medical Sciences, Ishikawa Prefectural Nursing University
nsg02-13/ky045059301600033210
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
More information研修コーナー
l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,
More information様式)
研究報告書 研究課題名 : 細胞膜脂質による分裂軸方向の制御とがん化に伴う変化 ( 研究領域 : 代謝と機能制御 ) 研究者氏名 : 豊島文子 ( 研究期間 : 2005 年 10 月 1 日 ~ 2009 年 3 月 31 日 ) 研究報告書 1. 研究課題名細胞膜脂質による分裂軸方向の制御とがん化に伴う変化 2. 氏名豊島文子 3. 研究のねらい生物が卵からその固有の形を作っていく過程では 個々の細胞が一定の軸方向に沿って分裂する現象が重要な役割を果たす
More information保健医療大学大学案内本文2016.indd
KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES University Guide 2 3 7 11 12 14 15 17 18 19 20 Contents 2 Department of Nursing 4 5 Department of Nursing 6 Department of Medical Technology 8 9 Department
More information本文/YA9255C
pp. E- -SH X in vitro in vivo -SH Structure-based drug development and medical biological application of cathepsin specific inhibitors Nobuhiko Katunuma Institute for Health Sciences, Tokushima Bunri University,Nishihamabouji,
More informationO1-1 O1-2 O1-3 O1-4 O1-5 O1-6
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
More information1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
More information肺癌第50巻第4号
1 Department of Cancer and Thoracic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan; 2 Department of Thoracic Surgery, Aichi Cancer Center, Japan;
More information本文/AY380J
MHC-II II MHC-II MHC- II CD T T TCR T T MHC-II MHC-II T MHC-II MHC-II MHC-II MHC-II Ii Ii-MHC-II MHC-II antigen processing compartment MIIC Regulation of cell surface expression of MHC-II in dendritic
More information研究会プログラム.doc
10 6 0:30-0:40 Session 0:40-1:10 Rac Michelle Lennartz 1:10-1:40 nnos 1:40-2:10 2:10-2:20 Session 2:20-2:50 2:50-3:20 NMDA NR1 3:20-3:50 GABA 3:50-4:00 Session 4:00-4:30 4:30-5:00 Vacuolar-type H + -ATPase
More informationの活性化が背景となるヒト悪性腫瘍の治療薬開発につながる 図4 研究である 研究内容 私たちは図3に示すようなyeast two hybrid 法を用いて AKT分子に結合する細胞内分子のスクリーニングを行った この結果 これまで機能の分からなかったプロトオンコジン TCL1がAKTと結合し多量体を形
AKT活性を抑制するペプチ ド阻害剤の開発 野口 昌幸 北海道大学遺伝子病制御研究所 教授 広村 信 北海道大学遺伝子病制御研究所 ポスドク 岡田 太 北海道大学遺伝子病制御研究所 助手 柳舘 拓也 株式会社ラボ 研究員 ナーゼAKTに結合するタンパク分子を検索し これまで機能の 分からなかったプロトオンコジンTCL1がAKTと結合し AKT の活性化を促す AKT活性補助因子 であることを見い出し
More informationzsj2017 (Toyama) program.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
More information88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
More information_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf
88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88
More information< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
More information37-4.indd
ISSN 0916-3328 東京大学アイソトープ総合センター VOL. 37 NO. 4 2007. 3. 26 アイソトープ総合センターの将来展望 40 18 18 20 3 800 1/3 1300 14 18 20 3 19 2 生きた細胞内の分子過程を 時間 空間計測する蛍光プローブの開発 1. はじめに Fura-2 Fura-2 198 1, 2 3, 4 2. 生体脂質分子の機能とその分析
More information表1.eps
Vol.1 C ontents 1 2 cell-free EMBO J Proc. Natl. Acad. Sci. USA NatureEMBO J 3 RNA NatureEMBO J Nature EMBO J 4 5 HCV HCV HCV HCV RNA HCV in situ 6 7 8 Nat Struct Mol Biol J Biol Chem Nat Commun J Virol
More informationnsg04-28/ky208684356100043077
δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!
More information日本経済新聞社編『経済学の巨人危機と闘う─達人が読み解く先人の知恵』
2012 309pp. Yasuo Suzuki / I 2008 4 3-16 1 2 3 174 2013 winter / No.398 4 5 6 7 8 J S 9 10 11 12 13 14 15 16 17 II 9 2011 11 9 9 16 175 6-8 1 1 1 2 7 13 15 10 280 281-286 176 2013 winter / No.398 281 286-298
More informationジャーナル4表紙
Jichi Medical University Journal of Nursing 7 3 4 55 63 75 a 83 93 97 3 9 5 9 3 5 7 97 5 9 6 ) 5) ) 36) 35 336 3 4 9 34 56 78 9 36 7 67 3 3 4 3 97 3 5 5 7 5 3 3 4 5 97 5 9 979 7 8564 887 97948 4 4 6
More informationuntitled
13 13 2014 3 1415 TEL.0859-33-3531 / FAX.0859-33-3607 TEL 0859-38-6292 FAX 0859-38-6293 E-mail: gan-center@med.tottori-u.ac.jp 13 13 Department of Medical Oncology, Thomas Jefferson University) 1F 2F
More information1
GL (a) (b) Ph l P N P h l l Ph Ph Ph Ph l l l l P Ph l P N h l P l .9 αl B βlt D E. 5.5 L r..8 e g s e,e l l W l s l g W W s g l l W W e s g e s g r e l ( s ) l ( l s ) r e l ( s ) l ( l s ) e R e r
More information研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
More information第 14 回血管病理研究会 日時 : 平成 20 年 10 月 10 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ) CRP MPO-ANCA 125IU/l CT mpa
第 4 回血管病理研究会 日時 : 平成 20 年 0 月 0 日 ( 土 ) 会場 : 佐賀大学医学部臨床大講堂 3208 号室会長 : 徳永藏 ( 佐賀大学医学部病因病態科学講座 ). 67 2008 CRP MPO-ANCA 25IU/l 009 2 CT mpa GCA PSL 50 mg CRP MPO-ANCA mpa GCA 4 mpa ovarlap 2 TLR 2 2. 対象 方法
More information(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................
More information本文/YA1174C
RecF DNA RecA DNA RecA RecF Steve Kowalczykowski Susan Lovett RecJ Mimitou, E.P. & Symington, L.S.Nature,,. Zhu, Z., Chung, W.H., Shim, E.Y., Lee, S.E., & Ira, G. Cell,,. Gravel, S., Chapman, J.R., Magill,
More information64) M.L. Gefter, R.L. Russell: J. Mol. Biol., 39, 145 (1969) 65) F. Harada, F. Kimura and S. Nishimura: Biochim. Biophys. Acta., 182, 590 (1969) 65a) F.H.C. Crick: J. Mol, Biol., 19, 548 (1966); M. Nirenberg
More informationuntitled
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Int J Radiat Oncol Biol Phys 49 Cancer 101 Int J Radiat Oncol Biol Phys 60 Chest 124 Int J Radiat Oncol Biol Phys 56 Int J Radiat Oncol Biol Phys 49 Chest 124 Int J
More informationMicrosoft Word - プログラム(タイトル).docx
8:55-9:00 9:00-10:15 O1 O5 9:00 O1 1 1 2 1 1 2 9:15 O2 HDAC 1 1 1 1 2 3 9:30 O3 1 1 1 1 2 3 9:45 O4 inos/nox 1)2) 1) 1) 1. 2. 10:00 O5 GAD67-GFP knockin CRH GABA 1,2 2 3 4 2 1 2 3 4 10:15-10:25 10:25-11:25
More information/‚“1/ŒxŒ{‚×›î’æ’¶
60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:
More information_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
More information
本文/YA6280C
H., Hoshino, K., Kaisho, T., Kuwata, H., Takeushi, O., Takeshige,K.,Saitoh,T.,Yamaoka,S.,Yamamoto,N.,Yamamoto, S., Muta, T., Takeda, K., & Akira, S.Nature,,. Yamazaki, S., Muta, T., Matsuo, S., & Takeshige,
More information本文/YA4278I
pp. D- D-DAO DAO D- D- D- D- o- DAO-D- D-DAO DAO Hans Krebs FAD X DAO DAO DAO D- Structure and reaction mechanism of D-amino acid oxidase Yasuzo Nishina School of Health Sciences, Kumamoto University,
More information第86回日本感染症学会総会学術集会後抄録(I)
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
More information< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
More informationMicrosoft Word - web.docx
12 10 E 16:30 17:30 : ( ) " " ( ) 12 10 15:50 16:20 A 1 ( ) ( ) B ( ) ( ) D ( ) ( 12 11 B 10:00 12:00 " " ( ) ( ) 2 (10 ) A 1 ( ) 8:30 12:40 8:30 9:20 1 ( ) 1A-01 Cannabidiol-2',6'-dimethyl ether ( 1,
More information第59巻4,5号(10月号)/投稿規定・目次・表2・奥付・背
Special IssuePhysiology, psychology and treatment of eating disorders Reviews Originals Proceeding Case Report ob α α et al. et al et al Control of food intake Kyoichi Kishi, Kazuhito Rokutan, Takeshi
More informationver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1
ORYZA OIL & FAT CHEMICAL CO., LTD. ALPHA LIPOIC ACID --P () --P80 () --WSP8 () --L1 () --PC () --PC80 () --WSPC8 () --LC1 () ver. 5.1HS ver5.1 HS 1. ALPHA LIPOIC ACID 16 3 31 0331009 - () 19 5 24 0524001
More information日本消化器病学会雑誌第102巻第8号
χ χ χ χ χ χ χ χ β The Health Administration Center, Tohoku University ; Department of Gastroenterology, Tohoku University Hospital Department of Endoscopic Diagnostics and Therapeutics, Chiba University
More information15K00827 研究成果報告書
(TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem
More informationPeroxisome Proliferator-Activated Receptor a (PPARa)アゴニストの薬理作用メカニズムの解明
インスリンによる脂肪細胞の数とサイズの制御機構の解明 Clarification of Regulatory Mechanisms for Determining Number and Size of Adipocytes by Insulin 平成 25 年度論文博士申請者 指導教員 伊藤実 (Ito, Minoru) 本島清人 肥満は糖尿病 脂質異常症 高血圧 動脈硬化症などの生活習慣病の基盤となるリスクファクターである
More informationPowerPoint プレゼンテーション
0 1 2 3 4 5 6 1964 1978 7 0.0015+0.013 8 1 π 2 2 2 1 2 2 ( r 1 + r3 ) + π ( r2 + r3 ) 2 = +1,2100 9 10 11 1.9m 3 0.64m 3 12 13 14 15 16 17 () 0.095% 0.019% 1.29% (0.348%) 0.024% 0.0048% 0.32% (0.0864%)
More informationLetter585.pdf
http://nibs.lin.gr.jp/ 2 18 1985 29 1982 2013 3 12 7800 14.4 1997 35 44 2013 7 25 44 2020 3 6 60 2 2014 3 19 8 kg 1 Metastrongylus 2 3 4 1.. 2013.. 66 4 243 247. 2.. 2012.. 65 6 429 435. 4 20 2000 [1 2]
More information表紙PDF作成用/PDF表紙作成用
2008 Vol.50 No.1 Jpn J School Health Jpn J School Health Jpn J School Health Jpn J School Health Hosen Junior High School, Okayama City Notre Dame Seishin University Graduate School Jpn J School Health
More information_ _ _ _ _ _ _ _ _ _ _ _ _ _ _
1000101_ 1000102_ 1000103_ 1000301_ 1000302_ 1000303_ 1000401_ 1000402_ 1000403_ 1000701_ 1000702_ 1000703_ 1000801_ 1000802_ 1000803_ 1000901_ 1000902_ 1000903_ 1001001_ 1001002_ 1001003_ 1001101_ 1001102_
More information2007 Vol.56 No.6 総説 丸山浩樹
Reprinted from RADIOISOTOPES, Vol.56,.6 June 2007 Japan Radioisotope Association http : //www.jrias.or.jp/ α β α β ε m z α µ µ α m z m z µ µ Curr. Opin. Biotechnol J. Proteome Res Rapid Commun. Mass
More information8.1 Fubini 8.2 Fubini 9 (0%) 10 (50%) Carathéodory 10.3 Fubini 1 Introduction 1 (1) (2) {f n (x)} n=1 [a, b] K > 0 n, x f n (x) K < ( ) x [a
% 100% 1 Introduction 2 (100%) 2.1 2.2 2.3 3 (100%) 3.1 3.2 σ- 4 (100%) 4.1 4.2 5 (100%) 5.1 5.2 5.3 6 (100%) 7 (40%) 8 Fubini (90%) 2007.11.5 1 8.1 Fubini 8.2 Fubini 9 (0%) 10 (50%) 10.1 10.2 Carathéodory
More information7 π L int = gψ(x)ψ(x)φ(x) + (7.4) [ ] p ψ N = n (7.5) π (π +,π 0,π ) ψ (σ, σ, σ )ψ ( A) σ τ ( L int = gψψφ g N τ ) N π * ) (7.6) π π = (π, π, π ) π ±
7 7. ( ) SU() SU() 9 ( MeV) p 98.8 π + π 0 n 99.57 9.57 97.4 497.70 δm m 0.4%.% 0.% 0.8% π 9.57 4.96 Σ + Σ 0 Σ 89.6 9.46 K + K 0 49.67 (7.) p p = αp + βn, n n = γp + δn (7.a) [ ] p ψ ψ = Uψ, U = n [ α
More information第14〜15回 T細胞を介する免疫系.pptx
MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α
More information2019 1 5 0 3 1 4 1.1.................... 4 1.1.1......................... 4 1.1.2........................ 5 1.1.3................... 5 1.1.4........................ 6 1.1.5......................... 6 1.2..........................
More informationVarious function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,
More informationPAC PAC PAC
PAC PAC PAC + / 398,145,048 411,745,732 13,600,684 24,250,351 25,778,560 1,528,209 4,241,016 3,942,000 299,016 426,636,415 441,466,292 14,829,877 74,000,000 74,000,000 0 74,000,000 74,000,000 0 178,367,442
More informationDM
( ) FAX DM DM PR 300 - - - - - - - - - - - - - - - - - - 6 3 1 4 3 - - - - PR P173 FAX (2001) (2000) (1999) 1986 http://kimono-yamato.com/04-kiso/qa.html Q&A http://web.sfc.keio.ac.jp/~t00524sh/chousa/rich/kimonobegin.html
More information第61巻5・6号(12月号)/特集1頁目(本刷)
Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture
More informationRX501NC_LTE Mobile Router取説.indb
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 1 2 3 4 5 6 7 8 19 20 21 22 1 1 23 1 24 25 1 1 26 A 1 B C 27 D 1 E F 28 1 29 1 A A 30 31 2 A B C D E F 32 G 2 H A B C D 33 E 2 F 34 A B C D 2 E 35 2 A B C D 36
More informationCAR-T実施
Building a Clinical CAR-T Program - Jichi Medical University Experience l l l Anti-CD3/28 mabs & IL-2: 29% Anti-CD3/28 beads: 66% Retroviral: 41% Lentiviral: 54% T-Flasks: 22% Static Culture Bags: 35%
More information本文/YA3180D
pp. D- Frontier Science in Amino Acid and Protein Research D- D- N - D- D- D-DAP, EC D-DaaA Ser β- D D- Discovery of D-stereoselective amino acid amidases, and their use in kinetic resolution of amino
More informationβ β β β β β
β β β β β β β β β β β β β β β β β θ β α γ et al et al et al β β et al β et al in vivo et al γ et al et al et al et al et al et al Ectopic fat deposition, type 2 diabetes mellitus and cardiovascular diseases
More information1 9 v.0.1 c (2016/10/07) Minoru Suzuki T µ 1 (7.108) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1)
1 9 v..1 c (216/1/7) Minoru Suzuki 1 1 9.1 9.1.1 T µ 1 (7.18) f(e ) = 1 e β(e µ) 1 E 1 f(e ) (Bose-Einstein distribution function) *1 (8.1) (9.1) E E µ = E f(e ) E µ (9.1) µ (9.2) µ 1 e β(e µ) 1 f(e )
More information本文/AY380P
ARF-like GTPase RAS G RAS, RHO RAC, RAB, ARF ARL, RAN ARF RAB G ARF-like ARL GTPase ARF G ARL GTPase ARF ARL GTPase G ARF ARL GTPase-activating proteins GAPs ARF G N ARF N ARF GDP GTP N ARL ARL ARF N ARL
More information化学療法剤の適切な使い方について
1 2 3 4 5 6 7 Che E, in Cancer: Principles & Practice of Oncology (7th ed) in Devita, 2005 Marangolo M, Oncol Rep, 2006 hryniuk WM, Important Adv Oncol, 1988 8 Cancer: Principles & Practice of Oncology
More informationuntitled
47 48 10 49 2005.6.1 17 500 50 1988 1994.1.1 16 22 51 18 1989 2005 17 2006 18 4 12 18 2007 19 1 12 2007 19 H18.8. J.H. 20 19 52 53 42.9 54 50 50 3080 55 30 100 56 57 22 96 6.8 9.4 31.44 58 10 780 250 59
More information